Zealand Pharma Resumes Partnership Talks for Glepaglutide, CFO Says

MT Newswires · 2d ago
08:11 AM EST, 11/12/2026 (MT Newswires) -- Zealand Pharma (ZEAL.CO) reopened partnership talks for its glepaglutide rare-disease drug, Reuters reported Thursday, citing Chief Financial Officer Henriette Wennicke. The Danish biotechnology company is mainly searching for a global partner for the bowel syndrome treatment but remains open to other deals, Wennicke said, without disclosing a timeline.